柳智文

作者: 时间:2025-10-29 点击数:

柳智文,博士,讲师。主要从事天然多糖/无机杂化仿生材料的构建及生物医学应用研究。以第一作者和共同作者身份在Nat. Commun., Adv. Mater., ACS Nano, Adv. Sci.等期刊发表9篇论文。

代表性成果:

1.Liu Z, Guo K, Yan L, Zhang K, Wang Y, Ding X, Zhao N, Xu F J. Janus nanoparticles targeting extracellular polymeric substance achieve flexible elimination of drug-resistant biofilms. Nat. Commun. 2023, 14, 5132.

2.Liu Z, Zhao X, Yu B, Zhang C, Zhao N, Xu F J. Rough carbon–iron oxide nanohybrids for near-infrared-II light-responsive synergistic antibacterial therapy. ACS Nano, 2021, 15, 7482-7490.

3.Liu Z, Guo K, Zhao N, Xu F J. Polysaccharides-based nanohybrids: Promising candidates for biomedical materials. Sci. China Mater. 2019, 62, 1831-1836.

4. Dai X,Liu Z, Zhao X, Guo K, Ding X, Xu F J, Zhao N. NIR-II-responsive hybrid system achieves cascade-augmented antitumor immunity via genetic engineering of both bacteria and tumor cells. Adv. Mater. 2024, 2407927.

5. Zhao N, Jiao Z, Chen L, Liu Z, Zhao X. Xu F J. Hybrids of polysaccharides and inorganic nanoparticles: from morphological design to diverse biomedical applications. Acc. Mater. Res. 2023, 4, 1068-1082.

获奖:

1.北京市优秀毕业生

2.北京化工大学优秀学位论文

3.第六届抗菌科学与技术论坛优秀青年报告

4.中国医药生物技术协会生物医学成像技术分会2023学术年会优秀口头报告

5. 2021高分子学术论文报告会优秀墙报

6.第五届抗菌科学与技术论坛优秀墙报

7.北京大学博雅材思全国博士生论坛优秀口头报告

Copyright© 2025 天津商业大学大健康协同创新研究院